Structure-dependent inhibition of the ETS-family transcription factor PU.1 by novel heterocyclic diamidines
Open accessThe DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Abstract
ETS transcription factors mediate a wide array of cellular functions and are attractive targets for pharmacological control of gene regulation. We report the inhibition of the ETS-family member PU.1 with a panel of novel heterocyclic diamidines. These diamidines are derivatives of furamidine (DB75) in which the central furan has been replaced with selenophene and/or one or both of the bridging phenyl has been replaced with benzimidazole. Like all ETS proteins, PU.1 binds sequence specifically to 10-bp sites by inserting a recognition helix into the major groove of a 5'-GGAA-3' consensus, accompanied by contacts with the flanking minor groove. We showed that diamidines target the minor groove of AT-rich sequences on one or both sides of the consensus and disrupt PU.1 binding. Although all of the diamidines bind to one or both of the expected sequences within the binding site, considerable heterogeneity exists in terms of stoichiometry, site-site interactions and induced DNA conformation. We also showed that these compounds accumulate in live cell nuclei and inhibit PU.1-dependent gene transactivation. This study demonstrates that heterocyclic diamidines are capable of inhibiting PU.1 by targeting the flanking sequences and supports future efforts to develop agents for inhibiting specific members of the ETS family.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“a luminescence reduction of 11.8 ± 22.3% in the presence of the PU.1-motif intercalator DB2313 (Antony-Debré et al., 2017; Munde et al., 2014; P ≤ 0.0001; Table S5).”
From A novel molecular class that recruits HDAC/MECP2 complexes to PU.1 motifs reduces neuroinflammation (2023) · cites this paper as Munde et al., 2014
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tight control of gene expression in mammalian cells by tetracycline-responsive promoters.
Gossen, M., & Bujard, H. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.12.5547 · Cited by 4,943 · cited 1×
“Separately, the CMV promoter of a commercial enhanced green fluorescent protein (EGFP) reporter plasmid (pEGFPLuc; Clontech) was replaced with a synthetic enhancer element consisting of five tandem repeats of the B site, spaced one helical-turn apart and followed by a minimal TATA-box promoter (33).”
A practical guide to evaluating colocalization in biological microscopy
Dunn, K. W., Kamocka, M. M., & McDonald, J. H. (2011) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00462.2010 · Cited by 2,038
Smithers, D. W. (1956) · The Lancet · doi:10.1016/s0140-6736(56)91184-9 · Cited by 1,791
Automatic and Quantitative Measurement of Protein-Protein Colocalization in Live Cells
Costes, S. V., Daelemans, D., Cho, E. H., Dobbin, Z., Pavlakis, G., & Lockett, S. (2004) · Biophysical Journal · doi:10.1529/biophysj.103.038422 · Cited by 1,424
Transcription regulation and animal diversity
Levine, M., & Tjian, R. (2003) · Nature · doi:10.1038/nature01763 · Cited by 1,309
Transcription factors as targets for cancer therapy
Darnell, J. E. (2002) · Nature Reviews Cancer · doi:10.1038/nrc906 · Cited by 1,194 · cited 1×
“Fitted values from Equation (3) in Supplementary Methods.”
BackgroundThe ETS-domain transcription factor family
Sharrocks, A. D. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35099076 · Cited by 1,086
Structure and evolution of transcriptional regulatory networks
Babu, M. M., Luscombe, N. M., Aravind, L., Gerstein, M., & Teichmann, S. A. (2004) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2004.05.004 · Cited by 763
Molecular biology of the Ets family of transcription factors
Oikawa, T., & Yamada, T. (2003) · Gene · doi:10.1016/s0378-1119(02)01156-3 · Cited by 688
for the Multiple Sclerosis Genetics Group, Gregory, S. G., Schmidt, S., Seth, P., Oksenberg, J. R., Hart, J., Prokop, A., Caillier, S. J., Ban, M., Goris, A., et al. (2007) · Nature Genetics · doi:10.1038/ng2103 · Cited by 657
Doxorubicin Induces Apoptosis in Normal and Tumor Cells via Distinctly Different Mechanisms
Wang, S., Konorev, E. A., Kotamraju, S., Joseph, J., Kalivendi, S., & Kalyanaraman, B. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400944200 · Cited by 611
Self-citationGenome-wide analysis of ETS-family DNA-binding in vitro and in vivo
Wei, G., Badis, G., Berger, M. F., Kivioja, T., Palin, K., Enge, M., Bonke, M., Jolma, A., Varjosalo, M., Gehrke, A. R., et al. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.106 · Cited by 568 · cited 1×
“The flanking sequences are nonrandom and genomic studies have established clear sequence preferences for high-affinity binding by subsets of ETS members in vivo (42).”
BackgroundGenomic and biochemical insights into the specificity of ETS transcription factors
Hollenhorst, P. C., McIntosh, L. P., & Graves, B. J. (2011) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.79.081507.103945 · Cited by 490
Circular Dichroism and Linear Dichroism
Rodger, A. (2014) · Encyclopedia of Analytical Chemistry · doi:10.1002/9780470027318.a5402.pub2 · Cited by 469
Ets target genes: past, present and future
Sementchenko, V. I., & Watson, D. K. (2000) · Oncogene · doi:10.1038/sj.onc.1204034 · Cited by 371
PU.1 Regulates Expression of the Interleukin-7 Receptor in Lymphoid Progenitors
DeKoter, R. P., Lee, H.-J., & Singh, H. (2002) · Immunity · doi:10.1016/s1074-7613(02)00269-8 · Cited by 319
Efficient and targeted delivery of siRNA in vivo
Shim, M. S., & Kwon, Y. J. (2010) · The FEBS Journal · doi:10.1111/j.1742-4658.2010.07904.x · Cited by 309
Ets proteins in biological control and cancer
Hsu, T., Trojanowska, M., & Watson, D. K. (2004) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20012 · Cited by 287
Receptor-ligand interactions; a practical approach
(1993) · General Pharmacology: The Vascular System · doi:10.1016/0306-3623(93)90342-u · Cited by 196
A complex task? Direct modulation of transcription factors with small molecules
Koehler, A. N. (2010) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2010.03.022 · Cited by 189
ETS transcription factors: Possible targets for cancer therapy
Oikawa, T. (2004) · Cancer Science · doi:10.1111/j.1349-7006.2004.tb03320.x · Cited by 184
Allosteric modulation of DNA by small molecules
Chenoweth, D. M., & Dervan, P. B. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0906532106 · Cited by 171
SpliceAid-F: a database of human splicing factors and their RNA-binding sites
Giulietti, M., Piva, F., D’Antonio, M., D’Onorio De Meo, P., Paoletti, D., Castrignanò, T., D’Erchia, A. M., Picardi, E., Zambelli, F., Principato, G., et al. (2013) · Nucleic Acids Research · doi:10.1093/nar/gks997 · Cited by 146
Penaranda, C., Kuswanto, W., Hofmann, J., Kenefeck, R., Narendran, P., Walker, L. S. K., Bluestone, J. A., Abbas, A. K., & Dooms, H. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1203692109 · Cited by 143
Okamoto, T., Zobel, K., Fedorova, A., Quan, C., Yang, H., Fairbrother, W. J., Huang, D. C. S., Smith, B. J., Deshayes, K., & Czabotar, P. E. (2013) · ACS Chemical Biology · doi:10.1021/cb3005403 · Cited by 136 · cited 1×
“They also complement macromolecular approaches for inhibiting gene expression, such as anti-sense oligonucleotides, RNAi and stapled peptides, which suffer from weak metabolic stability and poor cell uptake properties in vivo (5,6).”
BackgroundGalang, C. K., Muller, W. J., Foos, G., Oshima, R. G., & Hauser, C. A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311887200 · Cited by 132
Acute Modulation of Toll-Like Receptors by Insulin
Ghanim, H., Mohanty, P., Deopurkar, R., Ling Sia, C., Korzeniewski, K., Abuaysheh, S., Chaudhuri, A., & Dandona, P. (2008) · Diabetes Care · doi:10.2337/dc08-0561 · Cited by 123
Diamidines for human African trypanosomiasis.
Paine, M. F., Wang, M. Z., Generaux, C., et al. (2010) · PubMed · Cited by 117
Cellular uptake of N-methylpyrrole/N-methylimidazole polyamide-dye conjugates
Belitsky, J. M. (2002) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(02)00204-3 · Cited by 112
Wang, L., Bailly, C., Kumar, A., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.1.12 · Cited by 104
Self-citationMechanisms of in vivo binding site selection of the hematopoietic master transcription factor PU.1
Pham, T.-H., Minderjahn, J., Schmidl, C., Hoffmeister, H., Schmidhofer, S., Chen, W., Längst, G., Benner, C., & Rehli, M. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt355 · Cited by 102 · cited 1×
“AT-rich flanking sequences, a feature distinct from other ETS classes (30,43).”
BackgroundSzymczyna, B. R., & Arrowsmith, C. H. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004294200 · Cited by 99 · cited 2×
“AT-rich flanking sequences, a feature distinct from other ETS classes (30,43).”
BackgroundHo, W. C., Dickson, K. M., & Barker, P. A. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3494 · Cited by 92
Thiophene-Based Diamidine Forms a “Super” AT Binding Minor Groove Agent
Mallena, S., Lee, M. P. H., Bailly, C., et al. (2004) · Journal of the American Chemical Society · doi:10.1021/ja048175m · Cited by 84
Cyclic Pyrrole−Imidazole Polyamides Targeted to the Androgen Response Element
Chenoweth, D. M., Harki, D. A., Phillips, J. W., Dose, C., & Dervan, P. B. (2009) · Journal of the American Chemical Society · doi:10.1021/ja901309z · Cited by 79
Nhili, R., Peixoto, P., Depauw, S., Flajollet, S., Dezitter, X., Munde, M. M., Ismail, M. A., Kumar, A., Farahat, A. A., Stephens, C. E., et al. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks971 · Cited by 79
Self-citationDickinson, L. A., Trauger, J. W., Baird, E. E., Dervan, P. B., Graves, B. J., & Gottesfeld, J. M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.18.12765 · Cited by 71
Lansiaux, A., Tanious, F. A., Mishal, Z., et al. (2002) · PubMed · Cited by 62
Evaluation of the Influence of Compound Structure on Stacked-Dimer Formation in the DNA Minor Groove
Wang, L., Carrasco, C., Kumar, A., et al. (2001) · Biochemistry · doi:10.1021/bi002301r · Cited by 58
Self-citationTargeting the Ets Binding Site of the HER2/neuPromoter with Pyrrole-Imidazole Polyamides
Chiang, S.-Y., Bürli, R. W., Benz, C. C., Gawron, L., Scott, G. K., Dervan, P. B., & Beerman, T. A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000820200 · Cited by 56
Targeted Chemical Wedges Reveal the Role of Allosteric DNA Modulation in Protein−DNA Assembly
Moretti, R., Donato, L. J., Brezinski, M. L., Stafford, R., Hoff, H., Thorson, J. S., Dervan, P. B., & Ansari, A. Z. (2008) · ACS Chemical Biology · doi:10.1021/cb700258r · Cited by 52
Peixoto, P., Liu, Y., Depauw, S., Hildebrand, M.-P., Boykin, D. W., Bailly, C., Wilson, W. D., & David-Cordonnier, M.-H. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn208 · Cited by 52
Self-citationThe diverse role of the ETS family of transcription factors in cancer.
Gilliland, D. G. (2001) · PubMed · Cited by 44
Functional Analysis of the Human Interleukin 2 Receptor γ Chain Gene Promoter
Ohbo, K., Takasawa, N., Ishii, N., Tanaka, N., Nakamura, M., & Sugamura, K. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.13.7479 · Cited by 39
Eisenbeis, C. F., Singh, H., & Storb, U. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.10.6452-6461.1993 · Cited by 38 · cited 1×
“Here we demonstrate, using the B motif of the Ig2–4 enhancer (32), a high-affinity PU.”
MethodTargeting a DNA Binding Motif of the EVI1 Protein by a Pyrrole–Imidazole Polyamide
Zhang, Y., Sicot, G., Cui, X., Vogel, M., Wuertzer, C. A., Lezon-Geyda, K., Wheeler, J., Harki, D. A., Muzikar, K. A., Stolper, D. A., et al. (2011) · Biochemistry · doi:10.1021/bi200962u · Cited by 35
Poon, G. M. K. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.342345 · Cited by 34
Self-citationMunde, M. M., Poon, G. M. K., & Wilson, W. D. (2013) · Journal of Molecular Biology · doi:10.1016/j.jmb.2013.02.010 · Cited by 31
Self-citationDNA Binding Regulates the Self-Association of the ETS Domain of PU.1 in a Sequence-Dependent Manner
Poon, G. M. K. (2012) · Biochemistry · doi:10.1021/bi300331v · Cited by 27
Self-citationLiu, Y., Collar, C. J., Kumar, A., Stephens, C. E., Boykin, D. W., & Wilson, W. D. (2008) · The Journal of Physical Chemistry B · doi:10.1021/jp804048c · Cited by 25
Self-citation
Research works printed but not linked: 3
- 2012, 8, 297
- Lansiaux, 2002, Cancer Research, 62, 7219
- Paine, 2010, Current opinion in investigational drugs (London, England : 2000), 11, 876
Cited by
Targeting Transcription Factors for Cancer Treatment
Lambert, M., Jambon, S., Depauw, S., & David-Cordonnier, M.-H. (2018) · Molecules · doi:10.3390/molecules23061479 · Cited by 352
PU.1 controls fibroblast polarization and tissue fibrosis
Wohlfahrt, T., Rauber, S., Uebe, S., Luber, M., Soare, A., Ekici, A., Weber, S., Matei, A.-E., Chen, C.-W., Maier, C., et al. (2019) · Nature · doi:10.1038/s41586-019-0896-x · Cited by 187
Self-citationPharmacological inhibition of the transcription factor PU.1 in leukemia
Antony-Debré, I., Paul, A., Leite, J., Mitchell, K., Kim, H. M., Carvajal, L. A., Todorova, T. I., Huang, K., Kumar, A., Farahat, A. A., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci92504 · Cited by 120
“Treatment with compounds led to a profound decrease in the growth of PU.1 URE–/– AML cells (IC50 for DB2115: 3.4 μM < IC50 for DB2313: 7.1 μM < IC50 for DB1976: 105 μM), while showing little effect on normal hematopoietic cells at similar concentrations (calculated IC50 for DB2115: 192 μM; DB2313: 240 μM; DB1976: 334…”
BackgroundMethodInfluentialSelf-citationConstrained chromatin accessibility in PU.1-mutated agammaglobulinemia patients
Le Coz, C., Nguyen, D. N., Su, C., Nolan, B. E., Albrecht, A. V., Xhani, S., Sun, D., Demaree, B., Pillarisetti, P., Khanna, C., et al. (2021) · Journal of Experimental Medicine · doi:10.1084/jem.20201750 · Cited by 69
Self-citationA novel molecular class that recruits HDAC/MECP2 complexes to PU.1 motifs reduces neuroinflammation
Ralvenius, W. T., Mungenast, A. E., Woolf, H., Huston, M. M., Gillingham, T. Z., Godin, S. K., Penney, J., Cam, H. P., Gao, F., Fernandez, C. G., et al. (2023) · Journal of Experimental Medicine · doi:10.1084/jem.20222105 · Cited by 29
“To date, two small-molecule screens targeting PU.1 have been published (Munde et al., 2014; Rustenhoven et al., 2018).”
Influential
Metadata
- Authors
- Munde, M., Wang, S., Kumar, A., Stephens, C. E., Farahat, A. A., Boykin, D. W., Wilson, W. D., & Poon, G. M. K.
- Affiliations
- Georgia State University (US)
- Corresponding author
- Poon, G. M. K.
- Venue
- Nucleic Acids Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2013-10-23
- Volume
- 42
- Issue
- 2
- Pages
- 1379-1390
- ISSN
- 0305-1048 (ISSN-L)
- 1362-4962
- PMC
- PMC3902942
- OpenAlex
- W2155557355
- Cited by
- 68
- References
- 50
- Citations by year
- 2025: 1 · 2024: 6 · 2023: 8 · 2022: 9 · 2021: 4 · 2020: 5 · 2019: 7 · 2018: 11 · 2017: 6 · 2016: 5 · 2015: 1 · 2014: 5
- FWCI
- 1.64
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Nucleic Acids Research (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Digital Archive @ GSU (submittedVersion, cc-by-nc)
- Counseling And Psychological Services Dissertations (Georgia State University) (submittedVersion, cc-by-nc)
- Funders
- Washington State University
- National Institute of Allergy and Infectious Diseases (R01AI064200, AI064200)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA and Nucleic Acid Chemistry
- Health Sciences › Medicine › Oncology › Metal complexes synthesis and properties
- Physical Sciences › Chemistry › Organic Chemistry › Synthesis and pharmacology of benzodiazepine derivatives
- Keywords
- PU.1, ETS transcription factors, selenophene, benzimidazole, minor groove binding, DNA binding inhibition, AT-rich sequences, transcriptional repression, gene transactivation, structure-activity relationship
- MeSH terms
- Proto-Oncogene Protein Spi-1, Benzamidines, Binding Sites, DNA, Humans, Immunoglobulin lambda-Chains, Nucleic Acid Conformation, Proto-Oncogene Proteins, Transcriptional Activation, Trans-Activators, AT Rich Sequence, HEK293 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.